Mutually beneficial interaction between scientific and clinical thought leaders and pharmaceutical, biotechnology and medical device pioneering firms serves the purpose of accelerating the discovery, development and distribution of life enhancing clinical assets. At ScienceFirst, we have developed a philosophy and methodology that transcend the concept of “KOL management.” Our clients benefit from our principles and practice that fosters active KOL collaboration built on transparency and trust.